Rapid Dose Therapeutics Corp. applied to the Ontario Securities Commission for an order revoking a failure-to-file cease trade order issued on August 26, 2022.
The Issuer had failed to file its annual audited financial statements and other continuous disclosure documents.
Having subsequently filed all outstanding documents, paid all fees, and provided an undertaking to hold an annual meeting, the Principal Regulator was satisfied that the test for revocation was met.
The cease trade order was revoked.